Active immunization against poliomyelitis.
作者信息
COX H R
出版信息
Bull N Y Acad Med. 1953 Dec;29(12):943-60.
Abstract
摘要
相似文献
1
Active immunization against poliomyelitis.脊髓灰质炎主动免疫
Bull N Y Acad Med. 1953 Dec;29(12):943-60.
2
Immunization against poliomyelitis.脊髓灰质炎免疫接种。
Pediatr Clin North Am. 1953;1(1A):49-51.
3
[Immunization against poliomyelitis].[脊髓灰质炎免疫接种]
Prensa Med Mex. 1953 Apr;18(4):81-5.
4
Background for active immunization against poliomyelitis.脊髓灰质炎主动免疫的背景。
Pediatrics. 1955 Jan;15(1):107-13.
5
Immunization in poliomyelitis.脊髓灰质炎的免疫接种
J Bone Joint Surg Am. 1954 Oct;36-A(5):893-901; passim.
6
Active immunization against poliomyelitis; a review.脊髓灰质炎主动免疫；综述
S Afr Med J. 1955 Sep 3;29(36):833-44.
7
IMMUNIZATION against poliomyelitis.脊髓灰质炎免疫接种
Br Med J. 1952 Sep 6;2(4783):551-2.
8
Active immunization against poliomyelitis.脊髓灰质炎主动免疫
Acta Pathol Microbiol Scand Suppl. 1956;39(Suppl 111):17-26. doi: 10.1111/j.1600-0463.1956.tb06722.x.
9
[Anti-poliomyelitis vaccination in the infant. Study of simple immunization and immunization with combined vaccines].[婴儿的抗脊髓灰质炎疫苗接种。单纯免疫与联合疫苗免疫的研究]
Ann Pediatr (Paris). 1960 Mar 24;36:157-65.
10
Immunization against poliomyelitis.脊髓灰质炎免疫接种
Med J Aust. 1956 May 19;1(20):821-8. doi: 10.5694/j.1326-5377.1969.tb105675.x.
引用本文的文献
1
Elements in the Development of a Production Process for Modified Vaccinia Virus Ankara.改良安卡拉痘苗病毒生产工艺开发中的要素
Microorganisms. 2013 Nov 1;1(1):100-121. doi: 10.3390/microorganisms1010100.
2
Matrix and backstage: cellular substrates for viral vaccines.基质与后台：病毒疫苗的细胞底物
Viruses. 2014 Apr 11;6(4):1672-700. doi: 10.3390/v6041672.
3
Can non-human primates serve as models for investigating dengue disease pathogenesis?非人灵长类动物能否作为研究登革热疾病发病机制的模型？
Front Microbiol. 2013 Oct 11;4:305. doi: 10.3389/fmicb.2013.00305.
4
Approach to control of poliomyelitis by immunological methods.通过免疫学方法控制脊髓灰质炎的途径。
Bull N Y Acad Med. 1955 Apr;31(4):259-74.
5
[Prevention of poliomyelitis; present and future].[脊髓灰质炎的预防；现状与未来]
Bull World Health Organ. 1955;13(3):447-72.
6
Living modified viruses as immunizing agents.活的修饰病毒作为免疫剂。
Br Med J. 1954 Jul 31;2(4882):259-65. doi: 10.1136/bmj.2.4882.259.
7
The historical feud over polio vaccine: how could a killed vaccine contain a natural disease?关于脊髓灰质炎疫苗的历史纷争：一种灭活疫苗怎么会含有天然疾病呢？
West J Med. 1999 Oct;171(4):271-3.
本文引用的文献
1
Rabies vaccine encephalomyelitis in relation to the incidence of animal rabies in Los Angeles.洛杉矶狂犬病疫苗性脑脊髓炎与动物狂犬病发病率的关系
Am J Public Health Nations Health. 1949 Jul;39(7):875-7. doi: 10.2105/ajph.39.7.875.
2
CULTIVATION OF RICKETTSIAE OF THE ROCKY MOUNTAIN SPOTTED FEVER, TYPHUS AND Q FEVER GROUPS IN THE EMBRYONIC TISSUES OF DEVELOPING CHICKS.落基山斑疹热、斑疹伤寒和Q热群立克次体在发育小鸡胚胎组织中的培养
Science. 1941 Oct 31;94(2444):399-403. doi: 10.1126/science.94.2444.399.
3
Cultivation of the Lansing Strain of Poliomyelitis Virus in Cultures of Various Human Embryonic Tissues.脊髓灰质炎病毒兰辛株在各种人胚胎组织培养物中的培养
Science. 1949 Jan 28;109(2822):85-7. doi: 10.1126/science.109.2822.85.
4
5
6
Studies on chick embryo adapted rabies virus. III. Duration of immunity in vaccinated dogs.鸡胚适应狂犬病病毒的研究。III. 接种疫苗犬的免疫持续时间。
Proc Soc Exp Biol Med. 1952 Jul;80(3):410-5. doi: 10.3181/00379727-80-19640.
7
Cultivation of poliomyelitis virus in tissue culture. I. Growth of the Lansing strain in human embryonic tissues.脊髓灰质炎病毒在组织培养中的培养。I. 兰辛株在人胚胎组织中的生长
Can J Med Sci. 1952 Jun;30(3):231-45. doi: 10.1139/cjms52-031.
8
Immunity to poliomyelitis.对脊髓灰质炎的免疫力。
Ann Intern Med. 1952 Jul;37(1):1-22. doi: 10.7326/0003-4819-37-1-1.
9
10
Multiplication of poliomyelitis viruses in tissue cultures of monkey testes. II. Direct isolation and typing of strains from human stools and spinal cords in roller tubes.脊髓灰质炎病毒在猴睾丸组织培养中的增殖。II. 滚管法从人粪便和脊髓中直接分离毒株及定型
Am J Hyg. 1952 May;55(3):339-46. doi: 10.1093/oxfordjournals.aje.a119525.
Zotero 插件